A051901

Phase I Trial of Methotrexate, Rituximab, Lenalidomide, and Nivolumab (Nivo-MR2) Induction Followed by Lenalidomide and Nivolumab Maintenance in Primary CNS Lymphoma
Status:

Open

Trial Type:

Contact:

Dr. Thomas Ollila
tollila@lifespan.org